SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-031128
Filing Date
2023-06-30
Accepted
2023-06-30 16:30:25
Documents
12
Period of Report
2023-06-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K pyxs-20230628.htm   iXBRL 8-K 67284
  Complete submission text file 0000950170-23-031128.txt   191615

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pyxs-20230628.xsd EX-101.SCH 2472
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pyxs-20230628_pre.xml EX-101.PRE 10289
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pyxs-20230628_lab.xml EX-101.LAB 14018
6 EXTRACTED XBRL INSTANCE DOCUMENT pyxs-20230628_htm.xml XML 4910
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40881 | Film No.: 231062186
SIC: 2834 Pharmaceutical Preparations